Fig. 2From: Computational approach towards the design of artemisinin–thymoquinone hybrids against main protease of SARS-COV-2Adapted from PubChemAnti-SARS-COV-2 structural formula drugs used as control ligands. A Anakinra, B azithromycin, C baricitinib, D chloroquine e E remdesivir.Back to article page